Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Trial of the PfSPZ Vaccine

This study has been completed.
The PATH Malaria Vaccine Initiative (MVI)
Information provided by (Responsible Party):
Sanaria Inc. Identifier:
First received: October 22, 2009
Last updated: September 9, 2014
Last verified: September 2014